Abstract
ObjectiveAnalysis of the results of patients who had been operated of renal cell carcinoma with vascular invasion in our institution, evaluation of prognostic factors and complications. MethodsRetrospective observational study of 37 patients diagnosed of renal cell carcinoma with vascular invasion operated between May 1999 and July 2013. We used the method of Kaplan–Meier survival analysis and the Mantel–Haenszel's test (log rank) and the Cox's proportional hazards analysis test to analyse the risk factors of mortality. ResultsThe median age was 60 years. Mean follow-up period was 42.1 months. The median overall survival and disease-free survival were 53.8 and 36.3 months, respectively. There was statistical association between overall survival and American Society of Anesthesiologists Classification score (p=0.047), tumor stage (p=0.003), lymph node involvement (p=0.024), presence of metastases (p=0.013), level of tumor thrombus (p=0.05) and histological type (p=0.001). 14 patients had grade IIIb complications or higher according to the Clavien Dindo classification, the most frequent was bleeding. ConclusionsRenal cell carcinoma with vascular invasion is a disease with high rate of mortality. Surgery is a therapeutic option that can be curative. The number of complications is important. Survival is conditioned by the American Society of Anesthesiologists Classification score, tumor stage, the level of tumor thrombus, lymph node involvement, metastasis and histological type.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.